These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11870362)

  • 21. Targeted conversion of the transthyretin gene in vitro and in vivo.
    Nakamura M; Ando Y; Nagahara S; Sano A; Ochiya T; Maeda S; Kawaji T; Ogawa M; Hirata A; Terazaki H; Haraoka K; Tanihara H; Ueda M; Uchino M; Yamamura K
    Gene Ther; 2004 May; 11(10):838-46. PubMed ID: 14961068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA oligonucleotide-assisted genetic manipulation increases transformation and homologous recombination efficiencies: Evidence from gene targeting of Dictyostelium discoideum.
    Kuwayama H; Yanagida T; Ueda M
    J Biotechnol; 2008 Feb; 133(4):418-23. PubMed ID: 18160166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides.
    Ishii KJ; Gursel I; Gursel M; Klinman DM
    Curr Opin Mol Ther; 2004 Apr; 6(2):166-74. PubMed ID: 15195929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of gene repair strategies in cell culture using a lacZ reporter system.
    Nickerson HD; Colledge WH
    Gene Ther; 2003 Sep; 10(18):1584-91. PubMed ID: 12907950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimising gene repair strategies in cell culture.
    Thorpe P; Stevenson BJ; Porteous DJ
    Gene Ther; 2002 Jun; 9(11):700-2. PubMed ID: 12032691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineered ribozymes as molecular tools for site-specific alteration of RNA sequence.
    Müller S
    Chembiochem; 2003 Oct; 4(10):991-7. PubMed ID: 14523916
    [No Abstract]   [Full Text] [Related]  

  • 27. The involvement of replication in single stranded oligonucleotide-mediated gene repair.
    Huen MS; Li XT; Lu LY; Watt RM; Liu DP; Huang JD
    Nucleic Acids Res; 2006; 34(21):6183-94. PubMed ID: 17088285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential therapeutic applications of decoy oligonucleotides.
    Tomita N; Morishita R; Tomita T; Ogihara T
    Curr Opin Mol Ther; 2002 Apr; 4(2):166-70. PubMed ID: 12044038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gene therapy and homologous recombination].
    Kobayashi I
    Nihon Rinsho; 1991 May; 49(5):1188-95. PubMed ID: 2067112
    [No Abstract]   [Full Text] [Related]  

  • 30. Mending the message.
    Garcia-Blanco MA
    Nat Biotechnol; 2003 Dec; 21(12):1448-9. PubMed ID: 14647326
    [No Abstract]   [Full Text] [Related]  

  • 31. Modification of hepatic genomic DNA using RNA/DNA oligonucleotides.
    Kren BT; Chen Z; Felsheim R; Roy Chowdhury N; Roy Chowdhury J; Steer CJ
    Gene Ther; 2002 Jun; 9(11):686-90. PubMed ID: 12032688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced oligonucleotide-directed gene targeting in mammalian cells following treatment with DNA damaging agents.
    Ferrara L; Parekh-Olmedo H; Kmiec EB
    Exp Cell Res; 2004 Oct; 300(1):170-9. PubMed ID: 15383324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triplex-mediated gene modification.
    Schleifman EB; Chin JY; Glazer PM
    Methods Mol Biol; 2008; 435():175-90. PubMed ID: 18370076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective oligonucleotide-mediated gene disruption in ES cells lacking the mismatch repair protein MSH3.
    Dekker M; Brouwers C; Aarts M; van der Torre J; de Vries S; van de Vrugt H; te Riele H
    Gene Ther; 2006 Apr; 13(8):686-94. PubMed ID: 16437133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic potential of decoy oligonucleotides strategy in cardiovascular diseases.
    Tomita N; Ogihara T; Morishita R
    Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):463-70. PubMed ID: 15030273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction/mutation of acid alpha-D-glucosidase gene by modified single-stranded oligonucleotides: in vitro and in vivo studies.
    Lu IL; Lin CY; Lin SB; Chen ST; Yeh LY; Yang FY; Au LC
    Gene Ther; 2003 Oct; 10(22):1910-6. PubMed ID: 14502220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ISIS 301012 gene therapy for hypercholesterolemia: sense, antisense, or nonsense?
    Ito MK
    Ann Pharmacother; 2007 Oct; 41(10):1669-78. PubMed ID: 17848425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosomal site-specific double-strand breaks are efficiently targeted for repair by oligonucleotides in yeast.
    Storici F; Durham CL; Gordenin DA; Resnick MA
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14994-9. PubMed ID: 14630945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted genome modification via triple helix formation.
    Kalish JM; Glazer PM
    Ann N Y Acad Sci; 2005 Nov; 1058():151-61. PubMed ID: 16394134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Scientific ethics of gene therapy for individuals. The urgency for DNA gene surgery].
    Valenzuela CY
    Rev Med Chil; 2003 Oct; 131(10):1208-14. PubMed ID: 14692314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.